Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan

Epidemiology and Infection

Volumn 134, Issue 6, 2006, Pages 1188-1194

  Qin, L ^a   Watanabe, H ^b   Yoshimine, H ^b   Guio, H ^b   Watanabe, K ^b   Kawakami, K ^c   Iwagaki, A ^d   Nagai, H ^e   Goto, H ^f   Kuriyama, T ^g   Fukuchi, Y ^h   Matsushima, T ⁱ   Kudoh, S ^j   Shimada, K ^k   Matsumoto, K ^l   Nagatake, T ^b   Mizota, T ^a   Oishi, K ^b  

^a Department of Social Environment Medicine ^*  (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

^f KYORIN UNIVERSITY   (Japan)

^g CHIBA UNIVERSITY   (Japan)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ KAWASAKI MEDICAL SCHOOL   (Japan)

^j NIPPON MEDICAL SCHOOL   (Japan)

^k Tokyo Senbai Hospital   (Japan)

^l Aino Memorial Hospital   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL DNA; CEFDITOREN; CEFTRIAXONE; CLARITHROMYCIN; DRUG BINDING PROTEIN; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; PENICILLIN G; PROTEIN ERM(B); PROTEIN MEF(A); UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; DATA COLLECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 33750369817     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006303     Document Type: Article

References (22)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clinical Infectious Diseases 1992; 15: 77-83.
2. Linares J, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clinical Infectious Diseases 1992; 15: 99-105.
3. Ishida T, et al. Etiology of community-acquired pneumonia in hospitalized patients: A 3-year prospective study in Japan. Chest 1998; 114: 1588-1593.
4. Rikitomi N, et al. Rapid increase of pneumococcal resistance to β-lactam and other antibiotics in isolates from the respiratory tract (Nagasaki, Japan: 1975-1994). Microbiology and Immunology 1996; 40: 899-905.
5. Watanabe H, et al. A comparative clinical study of pneumonia by penicillin-resistant and -sensitive Streptococcus pneumoniae in a community hospital. Respirology 2000; 5: 59-64.
6. Kasahara K, et al. Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: A pilot surveillance study. Journal of Clinical Microbiology 2005; 43: 1640-1645.
7. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, PA, 1998.
8. Ubukata K, Iwata S, Sunakawa K. In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. Journal of Infection and Chemotherapy 2003; 9: 221-226.
9. McGee L, et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. Journal of Clinical Microbiology 2001; 39: 2565-2571.
10. Yano H, et al. Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center. Journal of Clinical Microbiology 2000; 38: 625-629.
11. Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 2233-2239.
12. Watanabe H, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F pneumococci in North Thailand. Journal of Clinical Microbiology 2003; 41: 4178-4183.
13. Song JH, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Clinical Infectious Diseases 1999; 28: 1206-1211.
14. Aspa J, et al. Drug-resistant pneumococcal pneumonia: Clinical relevance and related factors. Clinical Infectious Diseases 2004; 38: 787-798.
15. Schrag SJ, et al. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrobial Agents and Chemotherapy 2004; 48: 3016-3023.
16. Bogaert D, et al. Pneumococcal vaccines: An update on current strategies. Vaccine 2004; 22: 2209-2220.
17. U.S. Centers for Disease Control. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 1997; 46 (RR-8): 1-24.
18. Mantese OC, et al. Prevalence of serotypes and antimicrobial resistance of invasive strains of Streptococcus pneumoniae. Journal of Pediatrics 2003; 79: 537-542.
19. Martens P, et al. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infectious Diseases 2004; 4: 21.
20. Mangtani P, Cutts F, Hall AJ. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: The state of the evidence. Lancet Infectious Diseases 2003; 3: 71-78.
21. Christenson B, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: A prospective study. Lancet 2001; 357: 1008-1011.
22. Ko KS, Song JH. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes. Journal of Infectious Diseases 2004; 190: 739-747.